Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 695 JPY -0.74% Market Closed
Market Cap: 135.2B JPY

Torii Pharmaceutical Co Ltd
Non-Reccuring Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torii Pharmaceutical Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Non-Reccuring Items
-ÂĄ200m
CAGR 3-Years
-71%
CAGR 5-Years
N/A
CAGR 10-Years
5%
Takeda Pharmaceutical Co Ltd
TSE:4502
Non-Reccuring Items
-ÂĄ72B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Non-Reccuring Items
-ÂĄ126B
CAGR 3-Years
-178%
CAGR 5-Years
-56%
CAGR 10-Years
-26%
Chugai Pharmaceutical Co Ltd
TSE:4519
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Non-Reccuring Items
-ÂĄ54.6B
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
132B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
4 730.38 JPY
Undervaluation 1%
Intrinsic Value
Price

See Also

What is Torii Pharmaceutical Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
-200m JPY

Based on the financial report for Dec 31, 2024, Torii Pharmaceutical Co Ltd's Non-Reccuring Items amounts to -200m JPY.

What is Torii Pharmaceutical Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
5%

Over the last year, the Non-Reccuring Items growth was -441%. The average annual Non-Reccuring Items growth rates for Torii Pharmaceutical Co Ltd have been -71% over the past three years , and 5% over the past ten years .

Back to Top